Bill > HB4298

This bill requires physicians performing breast implant surgery to obtain comprehensive written informed consent from patients starting January 1, 2026. The bill mandates that physicians provide patients with detailed information during an initial consultation, including a description of breast implant risks and surgical procedures, manufacturer patient information materials, FDA warning requirements, and guidance on reporting adverse events. Physicians must also use an informed consent checklist developed by the medical board in consultation with osteopathic medicine and surgery boards and patient advocacy groups. The checklist will include critical information about potential medical complications such as breast implant-associated cancers (like anaplastic large cell lymphoma), breast implant illness, and a reference to the FDA's black box warning on breast implant packaging. The goal is to ensure patients are thoroughly informed about the potential risks and complications associated with cosmetic breast implant surgery before consenting to the procedure, with the information being based on the most current medical knowledge available at the time of consultation.

Health and Social Services

https://legislature.mi.gov/Bills/Bill?ObjectName=2025-HB-4298